299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03181932 (ClinicalTrials.gov)	September 20, 2017	1/6/2017	AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With ...	A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Per ...	MRSA;Cystic Fibrosis	Drug: Vancomycin inhalation powder;Drug: Placebo inhalation powder	Savara Inc.	NULL	Completed	6 Years	N/A	All	188	Phase 3	United States;Canada
2	NCT01746095 (ClinicalTrials.gov)	March 2013	6/12/2012	Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic ...	A Phase 2, Randomized, Double Blind, Placebo-controlled Study of AeroVanc for the Treatment of Persi ...	Cystic Fibrosis	Drug: Vancomycin hydrochloride inhalation powder;Drug: Placebo inhalation powder	Savara Inc.	Synteract, Inc.;Cystic Fibrosis Foundation	Completed	12 Years	N/A	All	87	Phase 2	United States
3	NCT01594827 (ClinicalTrials.gov)	October 2012	7/5/2012	Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)	Persistent MRSA Eradication Protocol (PMEP)	Cystic Fibrosis	Drug: Inhaled Vancomycin;Drug: Placebo (Sterile Water);Drug: Rifampin;Drug: Trimethoprim /Sulfamethox ...	Johns Hopkins University	Case Western Reserve University;Cystic Fibrosis Foundation	Completed	12 Years	N/A	All	29	Phase 2	United States
4	NCT01509339 (ClinicalTrials.gov)	January 2012	9/1/2012	Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis	Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis	Cystic Fibrosis;Methicillin-resistant Staphylococcus Aureus	Drug: Vancomycin	Case Western Reserve University	Cystic Fibrosis Foundation Therapeutics	Active, not recruiting	18 Years	N/A	Both	10	Phase 1	United States
5	NCT01537666 (ClinicalTrials.gov)	November 2011	17/2/2012	Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics	Phase I, Reference-controlled, Dose Escalating Study to Examine the Pharmacokinetics and Safety of A ...	Healthy;Cystic Fibrosis	Drug: AeroVanc;Drug: IV vancomycin hydrochloride	Savara Inc.	INC Research Limited	Completed	18 Years	50 Years	All	25	Phase 1	Australia

First Previous1Next Last